General Information of Drug (ID: DM00R2I)

Drug Name
Ladiratuzumab vedotin
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Phase 2 [1]
Cross-matching ID
TTD ID
D0VQ8Q

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)